Advertisement

Medical Management and Complications Following TAVR

  • A. Claire Watkins
  • Anuj Gupta
  • Bartley P. Griffith
Chapter

Abstract

Immediate postoperative management of TAVR patients includes early ambulation, medical therapies, planning for early discharge, and monitoring of common and uncommon complications. Taken together, these actions allow for a smooth transition post-TAVR procedure.

Keywords

Clopidogrel Heart failure QRS interval Pacemaker Bleeding Stroke Atrial fibrillation Limb ischemia Acute kidney injury Infective endocarditis 

References

  1. 1.
    Chakravarty T, Søndergaard L, Friedman J, De Backer O, Berman D, Kofoed KF, Jilaihawi H, Shiota T, Abramowitz Y, Jørgensen TH, Rami T, Israr S, Fontana G, de Knegt M, Fuchs A, Lyden P, Trento A, Bhatt DL, Leon MB, Makkar RR, RESOLVE; SAVORY Investigators. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet. 2017;389(10087):2383–92.CrossRefGoogle Scholar
  2. 2.
    Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG, PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.CrossRefGoogle Scholar
  3. 3.
    Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, Smalling R, Lim S, Malaisrie SC, Kapadia S, Szeto WY, Greason KL, Kereiakes D, Ailawadi G, Whisenant BK, Devireddy C, Leipsic J, Hahn RT, Pibarot P, Weissman NJ, Jaber WA, Cohen DJ, Suri R, Tuzcu EM, Svensson LG, Webb JG, Moses JW, Mack MJ, Miller DC, Smith CR, Alu MC, Parvataneni R, D'Agostino RB Jr, Leon MB. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387(10034):2218–25.CrossRefGoogle Scholar
  4. 4.
    Kahlert P, Knipp SC, Schlamann M, Thielmann M, Al-Rashid F, Weber M, Johansson U, Wendt D, Jakob HG, Forsting M, Sack S, Erbel R, Eggebrecht H. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121(7):870–8.CrossRefGoogle Scholar
  5. 5.
    Miller DC, Blackstone EH, Mack MJ, Svensson LG, Kodali SK, Kapadia S, Rajeswaran J, Anderson WN, Moses JW, Tuzcu EM, Webb JG, Leon MB, Smith CR, PARTNER Trial Investigators and Patients, PARTNER Stroke Substudy Writing Group and Executive Committee. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg. 2012;143(4):832–843.e13.CrossRefGoogle Scholar
  6. 6.
    Van Mieghem NM, Schipper ME, Ladich E, Faqiri E, van der Boon R, Randjgari A, Schultz C, Moelker A, van Geuns RJ, Otsuka F, Serruys PW, Virmani R, de Jaegere PP. Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation. 2013;127(22):2194–201.CrossRefGoogle Scholar
  7. 7.
    Pasic M, Unbehaun A, Buz S, Drews T, Hetzer R. Annular rupture during transcatheter aortic valve replacement: classification, pathophysiology, diagnostics, treatment approaches, and prevention. JACC Cardiovasc Interv. 2015;8(1 Pt A):1–9.CrossRefGoogle Scholar
  8. 8.
    Yankelson L, Steinvil A, Gershovitz L, Leshem-Rubinow E, Furer A, Viskin S, Keren G, Banai S, Finkelstein A. Atrial fibrillation, stroke, and mortality rates after transcatheter aortic valve implantation. Am J Cardiol. 2014;114(12):1861–6.CrossRefGoogle Scholar
  9. 9.
    Amat-Santos IJ, Rodés-Cabau J, Urena M, DeLarochellière R, Doyle D, Bagur R, Villeneuve J, Côté M, Nombela-Franco L, Philippon F, Pibarot P, Dumont E. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59(2):178–88.CrossRefGoogle Scholar
  10. 10.
    Biviano AB, Nazif T, Dizon J, Garan H, Abrams M, Fleitman J, Hassan D, Kapadia S, Babaliaros V, Xu K, Rodes-Cabau J, Szeto WY, Fearon WF, Dvir D, Dewey T, Williams M, Kindsvater S, Mack MJ, Webb JG, Miller CD, Smith CR, Leon MB, Kodali S. Atrial fibrillation is associated with increased pacemaker implantation rates in the placement of AoRTic transcatheter valve (PARTNER) trial. J Atr Fibrillation. 2017;10(1):1494.CrossRefGoogle Scholar
  11. 11.
    January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. ACC/AHA task force members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):e199–267.CrossRefGoogle Scholar
  12. 12.
    Généreux P, Kodali SK, Green P, Paradis JM, Daneault B, Rene G, Hueter I, Georges I, Kirtane A, Hahn RT, Smith C, Leon MB, Williams MR. Incidence and effect of acute kidney injury after transcatheter aortic valve replacement using the new valve academic research consortium criteria. Am J Cardiol. 2013 Jan 1;111(1):100–5.CrossRefGoogle Scholar
  13. 13.
    Koifman E, Segev A, Fefer P, Barbash I, Sabbag A, Medvedovsky D, Spiegelstein D, Hamdan A, Hay I, Raanani E, Goldenberg I, Guetta V. Comparison of acute kidney injury classifications in patients undergoing transcatheter aortic valve implantation: predictors and long-term outcomes. Catheter Cardiovasc Interv. 2016;87(3):523–31.CrossRefGoogle Scholar
  14. 14.
    Wang J, Yu W, Zhou Y, Yang Y, Li C, Liu N, Hou X, Wang L. Independent risk factors contributing to acute kidney injury according to updated valve academic research consortium-2 criteria after Transcatheter aortic valve implantation: a meta-analysis and meta-regression of 13 studies. J Cardiothorac Vasc Anesth. 2017;31(3):816–26.CrossRefGoogle Scholar
  15. 15.
    Conte JV, Hermiller J Jr, Resar JR, Deeb GM, Gleason TG, Adams DH, Popma JJ, Yakubov SJ, Watson D, Guo J, Zorn GL 3rd, Reardon MJ. Complications after self-expanding transcatheter or surgical aortic valve replacement. Semin Thorac Cardiovasc Surg. 2017;29(3):321–30.CrossRefGoogle Scholar
  16. 16.
    Regueiro A, Linke A, Latib A, Ihlemann N, Urena M, Walther T, Husser O, Herrmann HC, Nombela-Franco L, Cheema AN, Le Breton H, Stortecky, Kapadia S, Bartorelli AL, Sinning JM, Amat-Santos I, Munoz-Garcia A, Lerakis S, Gutiérrez-Ibanes E, Abdel-Wahab M, Tchetche D, Testa L, Eltchaninoff H, Livi U, Castillo JC, Jilaihawi H, Webb JG, Barbanti M, Kodali S, de Brito FS Jr, Ribeiro HB, Miceli A, Fiorina C, Dato GM, Rosato F, Serra V, Masson JB, Wijeysundera HC, Mangione JA, Ferreira MC, Lima VC, Carvalho LA, Abizaid A, Marino MA, Esteves V, Andrea JC, Giannini F, Messika-Zeitoun D, Himbert D, Kim WK, Pellegrini C, Auffret V, Nietlispach F, Pilgrim T, Durand E, Lisko J, Makkar RR, Lemos PA, Leon MB, Puri R, San Roman A, Vahanian A, Søndergaard L, Mangner N, Rodés-Cabau J. Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death. JAMA. 2016;316(10):1083–92.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • A. Claire Watkins
    • 1
  • Anuj Gupta
    • 2
  • Bartley P. Griffith
    • 3
  1. 1.Department of Cardiothoracic SurgeryStanford University School of MedicineStanfordUSA
  2. 2.Division of CardiologyUniversity of Maryland, School of MedicineBaltimoreUSA
  3. 3.Division of Cardiac SurgeryUniversity of Maryland, School of MedicineBaltimoreUSA

Personalised recommendations